Superworth

Diagnostics and research stocks with the lowest PE ratio

Share price divided by earnings per share over the last twelve months. As of .

Ranked
20
of 74 diagnostics and research stocks we cover
Median
38.2×
Lowest
24.3×
LNTH
Range
24.3× to 170×
median 38.2×
24.3×170×
#CompanyPEPE vs its 10 yearsRevenue growth (TTM)Market cap
1LNTHLantheus24.3×53rd pct+2.3%$6.5B
2DGXQuest Diagnostics24.9×98th pct+9.1%$27.5B
3LHLabcorp29.4×79th pct+6.4%$28.9B
4IQVIQVIA32.0×39th pct+8.2%$42.5B
5AAgilent Technologies34.5×56th pct+8.6%$49.6B
6VCYTVeracyte35.0×14th pct+17.3%$3.9B
7CDNACareDx35.9×97th pct+38.9%$4.5B
8TMOThermo Fisher Scientific36.7×68th pct+8.3%$256.9B
9DHRDanaher37.9×65th pct+5.5%$162.6B
10MEDPMedpace38.0×66th pct+24.7%$18.1B
11MTDMettler-Toledo International38.4×57th pct+6.9%$34.2B
12ILMNIllumina44.0×31st pct+4.9%$35.7B
13BIOBio-Rad Laboratories44.4×54th pct+1.4%$9.8B
14IDXXIDEXX Laboratories46.5×20th pct+12.8%$52.1B
15RVTYRevvity72.2×90th pct+4.1%$16.9B
16CAICaris Life Sciences86.8×n/a+85.4%$9.1B
17NRCNRC Health97.0×100th pct−0.2%$536.6M
18WATWaters118×93rd pct+52.5%$46.4B
19ICCCImmucell132×87th pct+8.5%$95.9M
20BLLNBillionToOne170×n/a+90.1%$5.2B

Not ranked: 49 with a loss over the last year, 1 with a quarter missing, 1 with not a meaningful number. 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

PE for other groups

Other rankings of diagnostics and research stocks

The group